the Management of Benign Liver Lesions

1.     Klotz T, Montoriol PF, Da Ines D, et al. Hepatic haemangioma: Common and uncommon      imaging features. Diagn Interv Imaging 2013; 94(9):849–59.

2.     Libbrecht L, Cassiman D, Verslype C, et al. Clinicopathological features of focal nodular hyperplasia-like nodules in 130 cirrhotic explant livers. Am J Gastroenterol 2006;101(10):2341–6.

3.     Barbier L, Nault JC, Dujardin F, et al. Natural history of liver adenomatosis: A long-term observational study. J Hepatol 2019;71(6): 1184–92.

4.     4.Colombo M, Forner A, Ijzermans J, Paradis V, Reeves H, Vilgrain V, et al. EASL Clinical Practice Guidelines on the management of benign liver tumours. J Hepatol. 2016 Aug 1;65(2):386–98.

5.     Wanless IR, Party IW. Terminology of nodular hepatocellular lesions. Hepatology [Internet]. 1995;22(3). Available from: https://journals.lww.com/hep/fulltext/1995/09000/terminology of nodular hepatocellular_lesions.40.aspx

6.     Frenette C, Mendiratta-Lala M, Salgia R, Wong RJ, Sauer BG, Pillai A. ACG Clinical Guideline: Focal Liver Lesions. American Journal of Gastroenterology. 2024 Jul 1;119(7):1235–71.  

7.     Pompili M, Ardito F, Brunetti E, Cabibbo G, Calliada F, Cillo U, et al. Benign liver lesions 2022: Guideline for clinical practice of Associazione Italiana Studio del Fegato (AISF), Società Italiana di Radiologia Medica e Interventistica (SIRM), Società Italiana di Chirurgia (SIC), Società Italiana di Ultrasonologia in Medicina e Biologia (SIUMB), Associazione Italiana di Chirurgia Epatobilio-Pancreatica (AICEP), Società Italiana Trapianti d’Organo (SITO), Società Italiana di Anatomia Patologica e Citologia Diagnostica (SIAPEC-IAP) – Part II - Solid lesions. Digestive and Liver Disease. 2022 Dec 1;54(12):1614–22.